Delta price cost-effectiveness analysis of PCV21 vs PCV20 use in adults aged ≥65 years in Switzerland

20260 citationsJournal Articlediamond Open Access

Authors

PCV21 provides greater health and economic benefits than PCV20 and is cost-effective over a range of price premiums.

Partnerships for the goals

Published in: Journal of Medical Economics

Volume 29, Issue 1, pp. 334-344

Field-Weighted Citation Impact: 0.00